119-hr5629

HR
✓ Complete Data

To provide that the final rule of the Department of Health and Human Services titled "Medications for the Treatment of Opioid Use Disorder", except for the portion of the final rule relating to accreditation of opioid treatment programs, shall have no force or effect.

Login to track bills
Introduced:
Sep 30, 2025

Bill Statistics

3
Actions
0
Cosponsors
0
Summaries
0
Subjects
1
Text Versions
Yes
Full Text

AI Summary

No AI Summary Available

Click the button above to generate an AI-powered summary of this bill using Claude.

The summary will analyze the bill's key provisions, impact, and implementation details.

Latest Action

Sep 30, 2025
Referred to the House Committee on Energy and Commerce.

Actions (3)

Referred to the House Committee on Energy and Commerce.
Type: IntroReferral | Source: House floor actions | Code: H11100
Sep 30, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: Intro-H
Sep 30, 2025
Introduced in House
Type: IntroReferral | Source: Library of Congress | Code: 1000
Sep 30, 2025

Text Versions (1)

Introduced in House

Sep 30, 2025

Full Bill Text

Length: 1,772 characters Version: Introduced in House Version Date: Sep 30, 2025 Last Updated: Nov 15, 2025 6:09 AM
[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5629 Introduced in House

(IH) ]

<DOC>

119th CONGRESS
1st Session
H. R. 5629

To provide that the final rule of the Department of Health and Human
Services titled ``Medications for the Treatment of Opioid Use
Disorder'', except for the portion of the final rule relating to
accreditation of opioid treatment programs, shall have no force or
effect.

_______________________________________________________________________

IN THE HOUSE OF REPRESENTATIVES

September 30, 2025

Mrs. Houchin introduced the following bill; which was referred to the
Committee on Energy and Commerce

_______________________________________________________________________

A BILL

To provide that the final rule of the Department of Health and Human
Services titled ``Medications for the Treatment of Opioid Use
Disorder'', except for the portion of the final rule relating to
accreditation of opioid treatment programs, shall have no force or
effect.

Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1.
DISORDER.

(a) In General.--Except as provided by subsection

(b) , the final
rule of the Department of Health and Human Services titled
``Medications for the Treatment of Opioid Use Disorder'' (89 Fed. Reg.
7549; published February 2, 2024) shall have no force or effect.

(b) Exception.--Subsection

(a) shall not apply to the portion of
the final rule that makes modifications to subpart B of part 8 of title
42, Code of Federal Regulations (relating to accreditation of opioid
treatment programs).
<all>